For help on how to get the results you want, see our search tips.
237 results
Withdrawal type
Initial authorisation Remove Initial authorisation filter
-
List item
Withdrawn application: Raltegravir Viatris
raltegravir potassium, date of withdrawal: 22/02/2023, Initial authorisation, Last updated: 21/04/2023 -
List item
Withdrawn application: Aliqopa
copanlisib, date of withdrawal: 20/12/2021, Initial authorisation, Last updated: 10/02/2023 -
List item
Withdrawn application: Miplyffa
arimoclomol, date of withdrawal: 22/03/2022, Initial authorisation, Last updated: 08/02/2023 -
List item
Withdrawn application: Imbarkyd
bardoxolone methyl, date of withdrawal: 09/11/2022, Initial authorisation, Last updated: 07/02/2023 -
List item
Withdrawn application: Febseltiq
infigratinib, date of withdrawal: 11/10/2022, Initial authorisation, Last updated: 30/01/2023 -
List item
Withdrawn application: Hervelous
trastuzumab, date of withdrawal: 14/09/2022, Initial authorisation, Last updated: 13/12/2022 -
List item
Withdrawn application: Tuznue
trastuzumab, date of withdrawal: 14/09/2022, Initial authorisation, Last updated: 13/12/2022 -
List item
Withdrawn application: Exkivity
mobocertinib, date of withdrawal: 20/07/2022, Initial authorisation, Last updated: 24/11/2022 -
List item
Withdrawn application: Abylqis
arachis hypogaea extract, date of withdrawal: 17/12/2021, Initial authorisation, Last updated: 23/11/2022 -
List item
Withdrawn application: Sevsury
surufatinib, date of withdrawal: 01/08/2022, Initial authorisation, Last updated: 16/11/2022 -
List item
Withdrawn application: Parsaclisib Incyte Biosciences Distribution B.V.
parsaclisib, date of withdrawal: 27/06/2022, Initial authorisation, Last updated: 08/11/2022 -
List item
Withdrawn application: Dimherity
dimethyl fumarate, date of withdrawal: 22/02/2022, Initial authorisation, Last updated: 03/11/2022 -
List item
Withdrawn application: HemAryo
eptacog alfa (activated), date of withdrawal: 06/05/2022, Initial authorisation, Last updated: 27/09/2022 -
List item
Withdrawn application: Aduhelm
aducanumab, date of withdrawal: 20/04/2022, Initial authorisation, Last updated: 01/08/2022 -
List item
Withdrawn application: Sitoiganap
autologous glioma tumor cell lysates (inactivated), allogeneic glioma tumor cell lysates (inactivated), allogeneic glioma tumor cells (inactivated), autologous glioma tumor cells (inactivated), date of withdrawal: 02/05/2022, Initial authorisation, Last updated: 17/06/2022 -
List item
Withdrawn application: Neffy
epinephrine, date of withdrawal: 04/04/2022, Initial authorisation, Last updated: 20/05/2022 -
List item
Withdrawn application: Zektayos - Hepjuvo
obeticholic acid, date of withdrawal: 09/12/2021, Initial authorisation, Last updated: 08/04/2022 -
List item
Withdrawn application: Livmarli
maralixibat, date of withdrawal: 23/08/2021, Initial authorisation, Last updated: 17/12/2021 -
List item
Withdrawn application: Flynpovi
eflornithine, sulindac, date of withdrawal: 12/10/2021, Initial authorisation, Last updated: 07/12/2021 -
List item
Withdrawn application: Zynyz
retifanlimab, date of withdrawal: 14/10/2021, Initial authorisation, Last updated: 29/11/2021 -
List item
Withdrawn application: Oportuzumab monatox DLRC Pharma Services
oportuzumab monatox, date of withdrawal: 20/08/2021, Initial authorisation, Last updated: 20/10/2021 -
List item
Withdrawn application: Sildenafil FGK
sildenafil, date of withdrawal: 19/07/2021, Initial authorisation, Last updated: 05/10/2021 -
List item
Withdrawn application: Tibsovo
ivosidenib, date of withdrawal: 13/10/2020, Initial authorisation, Last updated: 16/04/2021 -
List item
Withdrawn application: Dexamethasone Taw
dexamethasone phosphate, date of withdrawal: 20/01/2021, Initial authorisation, Last updated: 19/03/2021 -
List item
Withdrawn application: Puldysa
idebenone, date of withdrawal: 28/10/2020, Initial authorisation, Last updated: 18/01/2021